Last reviewed · How we verify
Placebo of Honghuaruyi Wan
Placebo of Honghuaruyi Wan is a Small molecule drug developed by Beijing University of Chinese Medicine. It is currently FDA-approved.
This is a placebo formulation with no active pharmacological mechanism.
At a glance
| Generic name | Placebo of Honghuaruyi Wan |
|---|---|
| Sponsor | Beijing University of Chinese Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a placebo of Honghuaruyi Wan, this product contains no active ingredients and produces therapeutic effects only through placebo mechanisms such as expectation and conditioning. Honghuaruyi Wan itself is a traditional Chinese medicine formulation, but the placebo version is used as a control in clinical trials rather than for direct therapeutic benefit.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Honghuaruyi Wan CI brief — competitive landscape report
- Placebo of Honghuaruyi Wan updates RSS · CI watch RSS
- Beijing University of Chinese Medicine portfolio CI